Anticancer Potential of Natural Products

Dear Colleagues,

Cancer becomes one of the most serious diseases, and major of the cutrrent cancer chemotherapy is insufficient for complete treatment of cancer, due to the adverse effects and the development of multidrug resistance. Natural products mediate their bioactivities through different cellular mechanisms, of which several compounds have been developed succssfully as anticancer agents. In addition, many of these products have been reported for their immunoregulatory property, which is supportive of cancer immunotherapy, one of the most promisin therapies for the treatment of cancer. Thus, further investigations on natural products could provide critical information for the development of effective anticancer agents. This special issue aims to investigate a journey of the development of natural products as effective anticancer agents. We thus welcome Original Research, Review, Mini Review, and Perspective articles on this theme, including but not limited to:

• Identification of natural products showing potential anticancer activity.
• Structural insights and medicinal chemistry for synthetic modifications on natural products.
• Oncology biology for testing potential anticancer activity of natural products.
• Molecular biology and modeling for identification of the molecular targets of natural products.
• Tumor immunity about natural products.

Dr. Yulin Ren
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Scientia Pharmaceutica is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.